159 related articles for article (PubMed ID: 6107852)
1. Increased production of prostaglandin D2 in patients with systemic mastocytosis.
Roberts LJ; Sweetman BJ; Lewis RA; Austen KF; Oates JA
N Engl J Med; 1980 Dec; 303(24):1400-4. PubMed ID: 6107852
[No Abstract] [Full Text] [Related]
2. Markedly increased synthesis of prostaglandin D2 in systemic mastocytosis.
Roberts LJ; Sweetman BJ; Lewis RA; Folarin VF; Austen KF; Oates JA
Trans Assoc Am Physicians; 1980; 93():141-7. PubMed ID: 7245571
[No Abstract] [Full Text] [Related]
3. Secretory diarrhea and prostaglandin D2 overproduction in systemic mastocytosis.
Poynard T; Nataf C; Messing B; Modigliani R; Lecompte T; Nicolas P; Dray F; Ferme C
N Engl J Med; 1982 Jul; 307(3):186. PubMed ID: 6953312
[No Abstract] [Full Text] [Related]
4. The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production.
Kootte AM; Haak A; Roberts LJ
Neth J Med; 1983; 26(1):18-20. PubMed ID: 6572798
[No Abstract] [Full Text] [Related]
5. Systemic mastocytosis: management of an unusual case with histamine (H1 and H2) antagonists and cyclooxygenase inhibition.
Crawhall JC; Wilkinson RD
Clin Invest Med; 1987 Jan; 10(1):1-4. PubMed ID: 2880686
[TBL] [Abstract][Full Text] [Related]
6. [A case of systemic proliferative disease of mast cells (mastocytosis)].
Hirnlowa L; Shwarek P; Wolek M
Pol Tyg Lek; 1971 Feb; 26(8):279-80. PubMed ID: 4396316
[No Abstract] [Full Text] [Related]
7. Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks.
Roberts LJ; Turk JW; Oates JA
Adv Shock Res; 1982; 8():145-52. PubMed ID: 7136941
[TBL] [Abstract][Full Text] [Related]
8. Systemic mastocytosis.
Postgrad Med; 1972 Mar; 51(3):270. PubMed ID: 4401654
[No Abstract] [Full Text] [Related]
9. Multiple nodular lesions of upper limbs: nodular mastocytosis.
Fenniche S; Marrak H; Zghal M; Khayat O; Debbiche A; Ben Ayed M; Mokhtar I
Dermatol Online J; 2002 Oct; 8(2):20. PubMed ID: 12546775
[No Abstract] [Full Text] [Related]
10. [Clinical picture, treatment and histochemical characteristics of polysaccharide and protein components of mast cells in the skin of patients with mastocytosis].
Mel'nikova VS; Lopunova ZhK
Vestn Dermatol Venerol; 1977 Aug; (8):27-30. PubMed ID: 73277
[No Abstract] [Full Text] [Related]
11. Increased formation of thromboxane in vivo in humans with mastocytosis.
Morrow JD; Oates JA; Roberts LJ; Zackert WE; Mitchell TA; Lazarus G; Guzzo C
J Invest Dermatol; 1999 Jul; 113(1):93-7. PubMed ID: 10417625
[TBL] [Abstract][Full Text] [Related]
12. Basophil/mast cell precursors in mast cell proliferative disorders.
Denburg JA; Telizyn S; Ahlstedt S; Olafsson JH; Roupe G; Bienenstock J
Clin Invest Med; 1986; 9(1):21-5. PubMed ID: 3955917
[TBL] [Abstract][Full Text] [Related]
13. General anesthesia in a child with urticaria pigmentosa.
Coleman MA; Liberthson RR; Crone RK; Levine FH
Anesth Analg; 1980 Sep; 59(9):704-6. PubMed ID: 6106441
[No Abstract] [Full Text] [Related]
14. Preferential generation of prostaglandin D2 by rat and human mast cells.
Lewis RA; Holgate ST; Roberts LJ; Oates JA; Austen KF
Kroc Found Ser; 1981; 14():239-54. PubMed ID: 6796654
[No Abstract] [Full Text] [Related]
15. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
Hollmann TJ; Brenn T; Hornick JL
Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
[TBL] [Abstract][Full Text] [Related]
16. [Systemic mastocytosis: clinical case].
Mardones P; Moyano C; Peña K; Quijada C
Rev Med Chil; 1998 Jul; 126(7):823-7. PubMed ID: 9830775
[TBL] [Abstract][Full Text] [Related]
17. Bullous mastocytosis.
Orkin M; Good RA; Clawson CC; Fisher I; Windhorst DB
Arch Dermatol; 1970 May; 101(5):547-64. PubMed ID: 4192086
[No Abstract] [Full Text] [Related]
18. Urticaria pigmentosa. Histaminuria and treatment.
Tabar AI; Vives R; Valcayo A; Montes M; Varela JI
Allergol Immunopathol (Madr); 1990; 18(2):101-3. PubMed ID: 1973586
[TBL] [Abstract][Full Text] [Related]
19. Minimal effect of complete H1 receptor blockade on urticaria pigmentosa.
Krause LB; Shuster S
Acta Derm Venereol; 1985; 65(4):338-40. PubMed ID: 2413691
[TBL] [Abstract][Full Text] [Related]
20. Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis.
Roberts LJ; Sweetman BJ
Prostaglandins; 1985 Sep; 30(3):383-400. PubMed ID: 3864190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
